Structure Info
- Chemspace ID
- CSCS20621660261 (Synthesis)
- IUPAC Name
- (4S)-4-[(2S,3R)-2-[(2S)-6-(5-{[(2R,4aR,6R,7R,8S,8aS)-6-{[(10S,11R,15R,16R)-16-(4-{[2-(dimethylamino)acetyl]oxy}-3,5-dimethoxyphenyl)-14-oxo-4,6,13-trioxatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1,3(7),8-trien-10-yl]oxy}-8-hydroxy-2-methyl-hexahydro-2H-pyrano[3,2-d][1,3]dioxin-7-yl]oxy}-5-oxopentanamido)-2-[(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-[(2S)-6-(5-{[(2R,4aR,6R,7R,8S,8aS)-6-{[(10S,11R,15R,16R)-16-(4-{[2-(dimethylamino)acetyl]oxy}-3,5-dimethoxyphenyl)-14-oxo-4,6,13-trioxatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1,3(7),8-trien-10-yl]oxy}-8-hydroxy-2-methyl-hexahydro-2H-pyrano[3,2-d][1,3]dioxin-7-yl]oxy}-5-oxopentanamido)-2-{2-[(2S)-2-[(2S)-2-(2-{2-[(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-(5-{[(2R,4aR,6R,7R,8S,8aS)-6-{[(10S,11R,15R,16R)-16-(4-{[2-(dimethylamino)acetyl]oxy}-3,5-dimethoxyphenyl)-14-oxo-4,6,13-trioxatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1,3(7),8-trien-10-yl]oxy}-8-hydroxy-2-methyl-hexahydro-2H-pyrano[3,2-d][1,3]dioxin-7-yl]oxy}-5-oxopentanamido)-3-hydroxybutanamido]-3-phenylpropanamido]-3-phenylpropanamido]-3-(4-hydroxyphenyl)propanamido]acetamido}acetamido)-3-hydroxypropanamido]-5-carbamimidamidopentanamido]acetamido}hexanamido]-5-carbamimidamidopentanamido]-3-carbamoylpropanamido]-3-carbamoylpropanamido]-3-phenylpropanamido]hexanamido]-3-hydroxybutanamido]-4-{[(1S)-3-carboxy-1-{[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}propyl]carbamoyl}butanoic acid
- Mol formula
- C218H278N32O79
- Mol weight
- 4611 Da
- Catalog Number(s)
- HY-P10777
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- -12.54
- Heavy atoms count
- 329
- Rotatable bond count
- 124
- Number of rings
- 26
- Carbon bond saturation, Fsp3
- 0.527
- Polar surface area (Å)
- 1563
- Hydrogen bond acceptors count
- 79
- Hydrogen bond donors count
- 40
- Zoom the structure
- CSCS20621660261
Items Overall 1 item from 1 supplier
Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
---|---|---|---|---|---|---|
MedChemExpress | TBD | United States To: | 90 | 1 mg | POA | |
Description: Names: ANG1009; Product Description: ANG1009 is a BBB-penatrable anticancer agent. ANG1009 is cytotoxic to a variety of tumor cells and can induce cell cycle arrest. ANG1009 can be used in the study of brain cancer .; Target: Peptide-Drug Conjugates (PDCs); CAS: 1220637-65-9 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire